Paul Alfred Boepple, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Puberty, Precocious | 18 | 2009 | 164 | 1.230 |
Why?
|
| Gonadotropin-Releasing Hormone | 33 | 2013 | 1148 | 1.180 |
Why?
|
| Follicle Stimulating Hormone | 14 | 2009 | 726 | 0.750 |
Why?
|
| Inhibins | 9 | 2013 | 210 | 0.640 |
Why?
|
| Hypogonadism | 15 | 2013 | 798 | 0.450 |
Why?
|
| Luteinizing Hormone | 20 | 2011 | 820 | 0.420 |
Why?
|
| Puberty | 9 | 2010 | 501 | 0.410 |
Why?
|
| Seminiferous Epithelium | 1 | 2008 | 9 | 0.310 |
Why?
|
| Phlebotomy | 1 | 2008 | 137 | 0.300 |
Why?
|
| Gonadal Steroid Hormones | 3 | 2008 | 702 | 0.270 |
Why?
|
| Testosterone | 14 | 2009 | 2472 | 0.270 |
Why?
|
| Research Subjects | 1 | 2008 | 249 | 0.270 |
Why?
|
| Receptors, LHRH | 6 | 2011 | 158 | 0.270 |
Why?
|
| Adrenal Glands | 4 | 2001 | 552 | 0.270 |
Why?
|
| Bone Development | 6 | 1999 | 472 | 0.250 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2008 | 369 | 0.230 |
Why?
|
| Safety | 1 | 2008 | 1149 | 0.230 |
Why?
|
| Body Height | 8 | 2001 | 1570 | 0.210 |
Why?
|
| Estradiol | 7 | 2008 | 1937 | 0.200 |
Why?
|
| Gonadotropins | 8 | 2007 | 241 | 0.190 |
Why?
|
| Obesity | 5 | 2020 | 12947 | 0.160 |
Why?
|
| Neurosecretory Systems | 3 | 2013 | 223 | 0.160 |
Why?
|
| Pituitary Gland | 4 | 2007 | 635 | 0.140 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 1998 | 701 | 0.140 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 5 | 2011 | 257 | 0.130 |
Why?
|
| Kallmann Syndrome | 4 | 2007 | 139 | 0.130 |
Why?
|
| Neuroectodermal Tumors | 1 | 2015 | 22 | 0.130 |
Why?
|
| Gonads | 2 | 1992 | 109 | 0.120 |
Why?
|
| Meconium Aspiration Syndrome | 1 | 2015 | 30 | 0.120 |
Why?
|
| Bariatric Surgery | 2 | 2020 | 992 | 0.120 |
Why?
|
| Reproduction | 2 | 2013 | 645 | 0.120 |
Why?
|
| Testis | 6 | 2013 | 794 | 0.120 |
Why?
|
| Infertility, Male | 2 | 2013 | 395 | 0.120 |
Why?
|
| Follicle Stimulating Hormone, Human | 1 | 2013 | 25 | 0.110 |
Why?
|
| Proteins | 2 | 1998 | 6032 | 0.110 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2012 | 61 | 0.100 |
Why?
|
| Hypercalciuria | 1 | 2012 | 31 | 0.100 |
Why?
|
| Hypophosphatemia, Familial | 1 | 2012 | 32 | 0.100 |
Why?
|
| Glycoproteins | 2 | 2002 | 2203 | 0.100 |
Why?
|
| Dyslipidemias | 1 | 2020 | 868 | 0.100 |
Why?
|
| Fanconi Syndrome | 1 | 2012 | 34 | 0.100 |
Why?
|
| Fibrous Dysplasia, Polyostotic | 1 | 1992 | 39 | 0.100 |
Why?
|
| Rickets | 1 | 2012 | 70 | 0.100 |
Why?
|
| Body Composition | 2 | 2009 | 2426 | 0.100 |
Why?
|
| Ovulation | 1 | 1992 | 181 | 0.100 |
Why?
|
| Ovarian Cysts | 1 | 1992 | 108 | 0.100 |
Why?
|
| Menstruation | 1 | 1992 | 307 | 0.090 |
Why?
|
| Central Nervous System Cysts | 1 | 2010 | 56 | 0.090 |
Why?
|
| Seminiferous Tubules | 1 | 2009 | 25 | 0.090 |
Why?
|
| Hypothalamic Diseases | 1 | 2011 | 134 | 0.080 |
Why?
|
| Estrogens | 2 | 2010 | 1522 | 0.080 |
Why?
|
| Gastric Bypass | 2 | 2020 | 818 | 0.080 |
Why?
|
| Weight Gain | 1 | 1999 | 2348 | 0.080 |
Why?
|
| Hypothalamus | 2 | 2007 | 999 | 0.080 |
Why?
|
| Growth | 1 | 1991 | 365 | 0.080 |
Why?
|
| Genetic Variation | 3 | 2012 | 6567 | 0.080 |
Why?
|
| Feedback, Physiological | 2 | 2008 | 476 | 0.080 |
Why?
|
| Ketoconazole | 3 | 2007 | 97 | 0.080 |
Why?
|
| Puberty, Delayed | 3 | 2007 | 121 | 0.080 |
Why?
|
| Erythrocyte Indices | 1 | 2008 | 144 | 0.070 |
Why?
|
| Amenorrhea | 1 | 2011 | 483 | 0.070 |
Why?
|
| Dehydroepiandrosterone Sulfate | 4 | 2001 | 241 | 0.070 |
Why?
|
| Child, Preschool | 12 | 2008 | 42232 | 0.070 |
Why?
|
| Ferritins | 1 | 2008 | 598 | 0.060 |
Why?
|
| Androgens | 2 | 1992 | 1286 | 0.060 |
Why?
|
| Feedback | 4 | 2001 | 791 | 0.060 |
Why?
|
| Child | 18 | 2010 | 80158 | 0.060 |
Why?
|
| Age Determination by Skeleton | 3 | 1999 | 126 | 0.060 |
Why?
|
| Weight Loss | 2 | 2013 | 2684 | 0.060 |
Why?
|
| Pedigree | 6 | 2012 | 4542 | 0.060 |
Why?
|
| Aromatase Inhibitors | 3 | 2007 | 513 | 0.060 |
Why?
|
| Male | 38 | 2020 | 360846 | 0.060 |
Why?
|
| Menarche | 2 | 1999 | 532 | 0.050 |
Why?
|
| Humans | 52 | 2020 | 761596 | 0.050 |
Why?
|
| Adult | 27 | 2020 | 221210 | 0.050 |
Why?
|
| 17-alpha-Hydroxypregnenolone | 1 | 2001 | 5 | 0.050 |
Why?
|
| Obesity, Morbid | 2 | 2013 | 1277 | 0.050 |
Why?
|
| 17-alpha-Hydroxyprogesterone | 1 | 2001 | 21 | 0.050 |
Why?
|
| Adolescent | 17 | 2020 | 88326 | 0.050 |
Why?
|
| Lipids | 1 | 2013 | 3341 | 0.050 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2001 | 56 | 0.050 |
Why?
|
| Bone and Bones | 1 | 1992 | 2568 | 0.050 |
Why?
|
| Androstenedione | 1 | 2001 | 131 | 0.050 |
Why?
|
| Hormone Antagonists | 1 | 2001 | 107 | 0.050 |
Why?
|
| Longitudinal Studies | 3 | 2008 | 14608 | 0.050 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2001 | 99 | 0.050 |
Why?
|
| Eunuchism | 1 | 2001 | 19 | 0.050 |
Why?
|
| Mutation | 6 | 2011 | 30053 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 3826 | 0.050 |
Why?
|
| Female | 29 | 2020 | 392705 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2011 | 829 | 0.050 |
Why?
|
| Hypertension | 2 | 2020 | 8540 | 0.040 |
Why?
|
| Leptin | 2 | 1998 | 1597 | 0.040 |
Why?
|
| Ovary | 2 | 1999 | 959 | 0.040 |
Why?
|
| Skinfold Thickness | 1 | 1999 | 162 | 0.040 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2001 | 618 | 0.040 |
Why?
|
| Orchiectomy | 1 | 2001 | 463 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2013 | 6391 | 0.040 |
Why?
|
| Depression, Chemical | 1 | 1998 | 184 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2008 | 2220 | 0.040 |
Why?
|
| Sperm Count | 2 | 2013 | 229 | 0.040 |
Why?
|
| Hormones | 1 | 2001 | 869 | 0.040 |
Why?
|
| Brain | 2 | 2015 | 27121 | 0.030 |
Why?
|
| Receptors, Leptin | 1 | 1998 | 350 | 0.030 |
Why?
|
| Fertility | 1 | 2001 | 771 | 0.030 |
Why?
|
| Sex Chromosome Aberrations | 1 | 1996 | 116 | 0.030 |
Why?
|
| Homozygote | 1 | 2001 | 1776 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 12149 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 1996 | 224 | 0.030 |
Why?
|
| Massachusetts | 1 | 2008 | 8833 | 0.030 |
Why?
|
| Disorders of Sex Development | 1 | 1996 | 129 | 0.030 |
Why?
|
| Body Mass Index | 3 | 2013 | 12953 | 0.030 |
Why?
|
| Lethargy | 1 | 2015 | 43 | 0.030 |
Why?
|
| Signal Transduction | 1 | 1998 | 23447 | 0.030 |
Why?
|
| DAX-1 Orphan Nuclear Receptor | 2 | 2009 | 29 | 0.030 |
Why?
|
| Uterus | 1 | 1999 | 649 | 0.030 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2015 | 80 | 0.030 |
Why?
|
| Growth Hormone | 2 | 1988 | 569 | 0.030 |
Why?
|
| Hypernatremia | 1 | 2015 | 78 | 0.030 |
Why?
|
| Echoencephalography | 1 | 2015 | 134 | 0.030 |
Why?
|
| Myoclonus | 1 | 2015 | 107 | 0.030 |
Why?
|
| Reference Values | 3 | 1997 | 4920 | 0.030 |
Why?
|
| Diabetes Insipidus | 1 | 2015 | 144 | 0.030 |
Why?
|
| Remission, Spontaneous | 2 | 2007 | 384 | 0.030 |
Why?
|
| Pulse Therapy, Drug | 1 | 2013 | 37 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 9032 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2001 | 3713 | 0.030 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIc | 1 | 2012 | 14 | 0.030 |
Why?
|
| Molecular Sequence Data | 4 | 2012 | 17635 | 0.030 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2012 | 44 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 3 | 2011 | 4415 | 0.030 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2012 | 186 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2011 | 1252 | 0.020 |
Why?
|
| Infant | 4 | 2008 | 36193 | 0.020 |
Why?
|
| Time Factors | 4 | 2009 | 39969 | 0.020 |
Why?
|
| Sexual Maturation | 2 | 1990 | 261 | 0.020 |
Why?
|
| Dehydroepiandrosterone | 3 | 1988 | 258 | 0.020 |
Why?
|
| Drug Administration Schedule | 3 | 2007 | 4853 | 0.020 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2012 | 383 | 0.020 |
Why?
|
| Circadian Rhythm | 3 | 1998 | 2576 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2015 | 1835 | 0.020 |
Why?
|
| Recurrence | 2 | 2013 | 8466 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 10766 | 0.020 |
Why?
|
| Breast | 1 | 1999 | 1967 | 0.020 |
Why?
|
| Case-Control Studies | 3 | 2013 | 22176 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 2012 | 623 | 0.020 |
Why?
|
| Olfaction Disorders | 2 | 2006 | 224 | 0.020 |
Why?
|
| Middle Aged | 8 | 2020 | 220921 | 0.020 |
Why?
|
| Receptors, Peptide | 1 | 2011 | 279 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 1988 | 1935 | 0.020 |
Why?
|
| Hypotension | 1 | 2015 | 879 | 0.020 |
Why?
|
| Cryptorchidism | 2 | 2002 | 151 | 0.020 |
Why?
|
| Menstrual Cycle | 1 | 1992 | 539 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 1990 | 681 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2012 | 963 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 1992 | 1972 | 0.020 |
Why?
|
| Linear Models | 1 | 1998 | 5872 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2012 | 13446 | 0.020 |
Why?
|
| Nutrition Disorders | 1 | 2009 | 205 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2013 | 6534 | 0.020 |
Why?
|
| Follow-Up Studies | 4 | 2007 | 39106 | 0.020 |
Why?
|
| Family Health | 1 | 2012 | 1257 | 0.020 |
Why?
|
| Somatomedins | 1 | 1988 | 179 | 0.020 |
Why?
|
| Oocytes | 1 | 2012 | 1166 | 0.020 |
Why?
|
| Organ Size | 2 | 2009 | 2254 | 0.020 |
Why?
|
| Ultrasonography | 2 | 1999 | 5971 | 0.020 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2007 | 62 | 0.020 |
Why?
|
| Remission Induction | 1 | 2013 | 2397 | 0.020 |
Why?
|
| Base Sequence | 3 | 2007 | 12441 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2011 | 1132 | 0.020 |
Why?
|
| Pituitary Hormone-Releasing Hormones | 1 | 1986 | 36 | 0.020 |
Why?
|
| Hypothalamic Neoplasms | 1 | 1986 | 21 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2007 | 5439 | 0.020 |
Why?
|
| Respiratory Insufficiency | 1 | 2015 | 1230 | 0.020 |
Why?
|
| Melatonin | 1 | 1991 | 669 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 1301 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2010 | 1129 | 0.020 |
Why?
|
| Phenotype | 4 | 2007 | 16592 | 0.020 |
Why?
|
| Adrenal Cortex | 1 | 1986 | 134 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 1996 | 2986 | 0.020 |
Why?
|
| Nitriles | 2 | 2001 | 971 | 0.020 |
Why?
|
| Triglycerides | 1 | 2013 | 2461 | 0.020 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 1986 | 98 | 0.020 |
Why?
|
| Periodicity | 2 | 1996 | 348 | 0.020 |
Why?
|
| Triazoles | 2 | 2001 | 903 | 0.020 |
Why?
|
| Prognosis | 2 | 2020 | 29629 | 0.020 |
Why?
|
| Young Adult | 3 | 2020 | 59260 | 0.010 |
Why?
|
| Gastrectomy | 1 | 2009 | 672 | 0.010 |
Why?
|
| Hamartoma | 1 | 1986 | 235 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2013 | 2382 | 0.010 |
Why?
|
| Genotype | 2 | 2009 | 12990 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2007 | 1163 | 0.010 |
Why?
|
| Transcription Factors | 2 | 2007 | 12130 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2020 | 80647 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2007 | 2748 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2007 | 1494 | 0.010 |
Why?
|
| Age Factors | 2 | 2009 | 18399 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2010 | 2209 | 0.010 |
Why?
|
| Aging | 2 | 1999 | 8710 | 0.010 |
Why?
|
| Testicular Hormones | 1 | 2002 | 188 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2002 | 378 | 0.010 |
Why?
|
| Estrogen Antagonists | 1 | 2001 | 150 | 0.010 |
Why?
|
| Cleft Palate | 1 | 2006 | 589 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2009 | 1615 | 0.010 |
Why?
|
| Patient Compliance | 2 | 2009 | 2690 | 0.010 |
Why?
|
| Heterozygote | 1 | 2007 | 2787 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2012 | 9542 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 4740 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 12973 | 0.010 |
Why?
|
| Cohort Studies | 3 | 2009 | 41495 | 0.010 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2002 | 407 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2006 | 3606 | 0.010 |
Why?
|
| Chorionic Gonadotropin | 1 | 2001 | 457 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1996 | 9610 | 0.010 |
Why?
|
| Prospective Studies | 3 | 2008 | 54423 | 0.010 |
Why?
|
| Diagnostic Services | 1 | 1978 | 34 | 0.010 |
Why?
|
| Dipeptides | 1 | 2000 | 391 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1991 | 5112 | 0.010 |
Why?
|
| Gene Expression | 1 | 2011 | 7581 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2006 | 4111 | 0.010 |
Why?
|
| Gonadotropins, Pituitary | 1 | 1997 | 69 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2009 | 2036 | 0.010 |
Why?
|
| Secretory Rate | 1 | 1996 | 81 | 0.010 |
Why?
|
| Pregnancy | 1 | 1999 | 29890 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 11076 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2007 | 3442 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1996 | 306 | 0.010 |
Why?
|
| Libido | 1 | 1997 | 119 | 0.010 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1978 | 395 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2015 | 26202 | 0.010 |
Why?
|
| Sleep | 1 | 1990 | 4768 | 0.010 |
Why?
|
| Erectile Dysfunction | 1 | 1997 | 444 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2001 | 1948 | 0.010 |
Why?
|
| X Chromosome | 1 | 1996 | 816 | 0.010 |
Why?
|
| DNA | 1 | 2007 | 7213 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 12690 | 0.010 |
Why?
|
| DNA Primers | 1 | 1996 | 2820 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1996 | 2217 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1996 | 2341 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2001 | 2161 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1991 | 861 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 4174 | 0.010 |
Why?
|
| Follicular Phase | 1 | 1990 | 143 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1996 | 2358 | 0.010 |
Why?
|
| Age of Onset | 1 | 1997 | 3306 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 17904 | 0.000 |
Why?
|
| Aged | 1 | 2020 | 169310 | 0.000 |
Why?
|
| Methods | 1 | 1987 | 1067 | 0.000 |
Why?
|
| Animals | 3 | 2012 | 168475 | 0.000 |
Why?
|
| Mice | 1 | 2012 | 81539 | 0.000 |
Why?
|
| Dogs | 1 | 1987 | 3839 | 0.000 |
Why?
|
| Cattle | 1 | 1987 | 3849 | 0.000 |
Why?
|
| Body Weight | 1 | 1988 | 4618 | 0.000 |
Why?
|
| Personnel, Hospital | 1 | 1978 | 285 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2002 | 64685 | 0.000 |
Why?
|
| Kidney | 1 | 1991 | 7048 | 0.000 |
Why?
|
| Costs and Cost Analysis | 1 | 1978 | 1668 | 0.000 |
Why?
|
| Referral and Consultation | 1 | 1978 | 3600 | 0.000 |
Why?
|
| Emergency Service, Hospital | 1 | 1978 | 7879 | 0.000 |
Why?
|